Skip to main content
. 2021 Jun 16;9(6):e002118. doi: 10.1136/jitc-2020-002118

Figure 4.

Figure 4

Performance of the DLS in prognosis prediction. (A) The ROC curve of DLS in DCB prediction, and the PFS and OS relative to the DLS (DLS cutoff: 0.55) in the retrospective MCC ICI-treated patients. (B) The ROC curve of DLS in DCB prediction, and the PFS and OS relative to the DLS (DLS cutoff: 0.55) in the prospective MCC ICI-treated patients. (C) The ROC curve of DLS in DCB prediction, and the PFS and OS relative to the DLS (DLS cutoff: 0.55) in the external VA test patients. P value was from log rank test. AUC, area under the receiver operating characteristic curve; DCB, durable clinical benefit; DLS, deeply learned score; HDLS, high DLS; ICI, immune checkpoint inhibitor; LDLS, low DLS; MCC, H Lee Moffitt Cancer Center and Research Institute; OS, overall survival; PFS, progression-freesurvival; ROC, receiver operating characteristic; VA, James A Haley Veterans’ Administration.